204 related articles for article (PubMed ID: 29104488)
1. Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer.
Lin VC; Huang SP; Huang CY; Yu CC; Yin HL; Huang TY; Lee CH; Lu TL; Bao BY
Int J Med Sci; 2017; 14(12):1301-1306. PubMed ID: 29104488
[No Abstract] [Full Text] [Related]
2. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer.
Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Juang SH; Bao BY
Sci Rep; 2015 Feb; 5():8556. PubMed ID: 25707771
[TBL] [Abstract][Full Text] [Related]
4. Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer.
Chen CS; Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Bao BY
Int J Med Sci; 2015; 12(3):243-7. PubMed ID: 25678841
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.
Oh JJ; Park S; Lee SE; Hong SK; Lee S; Lee HM; Lee JK; Ho JN; Yoon S; Byun SS
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1493-501. PubMed ID: 25764380
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.
Gu CY; Qin XJ; Qu YY; Zhu Y; Wan FN; Zhang GM; Sun LJ; Zhu Y; Ye DW
Medicine (Baltimore); 2016 Jul; 95(27):e4066. PubMed ID: 27399092
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.
Lee CH; Pao JB; Lu TL; Lee HZ; Lee YC; Liu CC; Huang CY; Lin VC; Yu CC; Yin HL; Huang SP; Bao BY
Int J Med Sci; 2016; 13(9):696-700. PubMed ID: 27647999
[TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
[TBL] [Abstract][Full Text] [Related]
9. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
10. Expression of hepatocyte growth factor in prostate cancer may indicate a biochemical recurrence after radical prostatectomy.
Nishida S; Hirohashi Y; Torigoe T; Nojima M; Inoue R; Kitamura H; Tanaka T; Asanuma H; Sato N; Masumori N
Anticancer Res; 2015 Jan; 35(1):413-8. PubMed ID: 25550581
[TBL] [Abstract][Full Text] [Related]
11. Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy.
Yu CC; Chen LC; Lin VC; Huang CY; Cheng WC; Hsieh AR; Chang TY; Lu TL; Lee CH; Huang SP; Bao BY
Cancer Med; 2019 Jun; 8(6):2777-2783. PubMed ID: 30993852
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.
Yu CC; Lin VC; Huang CY; Liu CC; Wang JS; Wu TT; Pu YS; Huang CH; Huang CN; Huang SP; Bao BY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S492-9. PubMed ID: 23354566
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer.
Huang SP; Lévesque E; Guillemette C; Yu CC; Huang CY; Lin VC; Chung IC; Chen LC; Laverdière I; Lacombe L; Fradet Y; Chang TY; Lee HZ; Juang SH; Bao BY
Int J Cancer; 2014 Dec; 135(11):2661-7. PubMed ID: 24740842
[TBL] [Abstract][Full Text] [Related]
14. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.
Cooperberg MR; Pasta DJ; Elkin EP; Litwin MS; Latini DM; Du Chane J; Carroll PR
J Urol; 2005 Jun; 173(6):1938-42. PubMed ID: 15879786
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
[TBL] [Abstract][Full Text] [Related]
16. The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.
Perez CA; Chen H; Shyr Y; Courtney R; Zheng W; Cai Q; Hwang M; Jaboin J; Schleicher S; Moretti L; Wills M; Smith JA; Lu B
J Urol; 2010 May; 183(5):2062-9. PubMed ID: 20303520
[TBL] [Abstract][Full Text] [Related]
17. Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Ting WC; Chen LM; Huang LC; Liu CC; Chen CW; Hsieh CJ; Yang WH; Chang TY; Lee HZ; Bao BY
Ann Surg Oncol; 2010 Jan; 17(1):312-22. PubMed ID: 19777185
[TBL] [Abstract][Full Text] [Related]
18. A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer.
Huang EY; Chang YJ; Huang SP; Lin VC; Yu CC; Huang CY; Yin HL; Chang TY; Lu TL; Bao BY
J Cell Mol Med; 2018 Jul; 22(7):3661-3670. PubMed ID: 29682886
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
[TBL] [Abstract][Full Text] [Related]
20. Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?
Zhao Z; Stephan C; Weickmann S; Jung M; Kristiansen G; Jung K
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
